LV10384A - Constructed for the stabilization of blood plasma in the pasteurization time - Google Patents

Constructed for the stabilization of blood plasma in the pasteurization time

Info

Publication number
LV10384A
LV10384A LV920497A LV920497A LV10384A LV 10384 A LV10384 A LV 10384A LV 920497 A LV920497 A LV 920497A LV 920497 A LV920497 A LV 920497A LV 10384 A LV10384 A LV 10384A
Authority
LV
Latvia
Prior art keywords
blood plasma
stabilization
constructed
plasma
pasteurization
Prior art date
Application number
LV920497A
Other languages
Latvian (lv)
Other versions
LV10384B (en
Inventor
Thierry Burnouf
Miryana Burnouf
Original Assignee
Centre Regional De Transfusion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Regional De Transfusion filed Critical Centre Regional De Transfusion
Publication of LV10384A publication Critical patent/LV10384A/en
Publication of LV10384B publication Critical patent/LV10384B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/104Aminoacyltransferases (2.3.2)
    • C12N9/1044Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/16Blood plasma; Blood serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023Heat
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6443Coagulation factor XIa (3.4.21.27)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21027Coagulation factor XIa (3.4.21.27)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composition for stabilizing blood plasma, whole or lacking cryoproteins, during pasteurization. The composition according to the invention is used for pasteurizing substantial volumes of plasma (up to several hundreds of litres). The invention also concerns a process for the pasteurization of plasma using said stabilizing composition. The pasteurized plasma obtained is for therapeutic use.
LVP-92-497A 1990-07-03 1992-12-24 Composition for stabilizing blood plasma during pasteurization LV10384B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9008375A FR2664165B1 (en) 1990-07-03 1990-07-03 COMPOSITION FOR STABILIZING BLOOD PLASMA DURING PASTEURIZATION.
PCT/FR1991/000493 WO1992000767A1 (en) 1990-07-03 1991-06-20 Composition for stabilizing blood plasma during pasteurization

Publications (2)

Publication Number Publication Date
LV10384A true LV10384A (en) 1995-02-20
LV10384B LV10384B (en) 1995-04-20

Family

ID=9398269

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-497A LV10384B (en) 1990-07-03 1992-12-24 Composition for stabilizing blood plasma during pasteurization

Country Status (22)

Country Link
EP (1) EP0497929B1 (en)
JP (1) JP3132828B2 (en)
AT (1) ATE135238T1 (en)
AU (1) AU8062991A (en)
CA (1) CA2065284A1 (en)
CZ (1) CZ281431B6 (en)
DE (1) DE69117920T2 (en)
DK (1) DK0497929T3 (en)
ES (1) ES2084821T3 (en)
FI (1) FI96918C (en)
FR (1) FR2664165B1 (en)
GR (1) GR3020048T3 (en)
HU (1) HU208404B (en)
LT (1) LT3419B (en)
LV (1) LV10384B (en)
NO (1) NO179127C (en)
PL (1) PL166579B1 (en)
PT (1) PT98190B (en)
RU (1) RU2045902C1 (en)
SK (1) SK279031B6 (en)
WO (1) WO1992000767A1 (en)
ZA (1) ZA914848B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687317B1 (en) 1992-02-13 1995-06-23 Aetsrn COMPOSITION FOR STABILIZING BLOOD PLASMA DURING PASTEURIZATION AND PASTEURIZED PLASMATIC SOLUTION FOR THERAPEUTIC USE.
DE4240103A1 (en) * 1992-05-26 1993-12-02 Behringwerke Ag Process for inactivating viruses in protein preparations
DE19508192A1 (en) 1995-03-09 1996-09-12 Behringwerke Ag Stable transglutaminase preparations and process for their preparation
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
WO2017155678A1 (en) * 2016-03-10 2017-09-14 Kindheart, Inc Fake blood for use in simulated surgical procedures

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2916711A1 (en) 1979-04-25 1980-11-06 Behringwerke Ag Blood coagulation factors and process for their manufacture
EP0035204B2 (en) 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
DE3045153A1 (en) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg METHOD FOR THE PRODUCTION OF BLOOD COagulation FACTORS AND THE PREPARATION OF FACTORS IX AND X THEREFORE PRODUCED
DE3336631A1 (en) * 1983-10-08 1985-04-18 Behringwerke Ag, 3550 Marburg METHOD FOR THE PASTEURIZATION OF PLASMA OR CONCENTRATES OF THE BLOOD COAGINING FACTORS II, VII, IX AND X
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK18288D0 (en) * 1988-01-15 1988-01-15 Nordisk Gentofte PROCEDURE FOR PASTEURIZATION OF Aqueous SOLUTIONS OF FACTOR VIII

Also Published As

Publication number Publication date
AU8062991A (en) 1992-02-04
DE69117920D1 (en) 1996-04-18
DK0497929T3 (en) 1996-07-22
HUT60148A (en) 1992-08-28
FI96918B (en) 1996-06-14
FI920934A0 (en) 1992-03-02
FI96918C (en) 1996-09-25
CS57992A3 (en) 1992-08-12
HU208404B (en) 1993-10-28
GR3020048T3 (en) 1996-08-31
HU9200701D0 (en) 1992-05-28
ZA914848B (en) 1992-04-29
NO920791L (en) 1992-02-28
EP0497929A1 (en) 1992-08-12
CZ281431B6 (en) 1996-09-11
JPH05501417A (en) 1993-03-18
LTIP264A (en) 1994-10-25
JP3132828B2 (en) 2001-02-05
FR2664165A1 (en) 1992-01-10
EP0497929B1 (en) 1996-03-13
NO920791D0 (en) 1992-02-28
ATE135238T1 (en) 1996-03-15
PT98190A (en) 1992-05-29
PT98190B (en) 1998-12-31
PL294037A1 (en) 1993-01-11
WO1992000767A1 (en) 1992-01-23
LV10384B (en) 1995-04-20
FR2664165B1 (en) 1992-10-16
RU2045902C1 (en) 1995-10-20
NO179127B (en) 1996-05-06
ES2084821T3 (en) 1996-05-16
DE69117920T2 (en) 1996-10-02
NO179127C (en) 1996-08-14
LT3419B (en) 1995-09-25
PL166579B1 (en) 1995-06-30
SK279031B6 (en) 1998-05-06
CA2065284A1 (en) 1992-01-04

Similar Documents

Publication Publication Date Title
NO832977L (en) PASTEURIZED HUMAN FIBRINOGEN (HF), PROCEDURE FOR ITS PREPARATION AND ITS USE
ES2032316T3 (en) PROCEDURE FOR THE STERILIZATION OF PLASMA OR PLASMA FRACTIONS.
RU93004727A (en) COMPOSITION FOR STABILIZING BLOOD PLASMA, METHOD FOR PASTERIZING PLASMA AND USING STABILIZED PLASMA IN THERAPY
ATE79031T1 (en) USE OF KETONE DERIVATIVES TO TREAT DEPRESSION.
DK0556096T3 (en) Preparation for stabilizing blood plasma during pasteurization and pasteurized plasma solution for therapeutic use
DK406184A (en) PROCEDURE FOR PASTEURIZATION OF HUMAN PLASMA
LV10384A (en) Constructed for the stabilization of blood plasma in the pasteurization time
DK418986A (en) PYRROLOBENZIMIDAZOLES, PYRROLOBENZOXAZOLES AND PYRROLOBENZTHIAZOLES, PROCEDURES FOR THE PREPARATION OF IT, AND MEDICINAL PRODUCTS CONTAINING THEREOF
ATE45675T1 (en) USE OF INTERFERON GAMMA (IFN-GAMMA) IN THE MANUFACTURE OF PREPARATIONS FOR THE TREATMENT OF RHEUMATIC DISEASES.
DE3464486D1 (en) Derivatives of n-(4-acetylaminophenacyl)-amine, their therapeutical use and process for their preparation
DE3774715D1 (en) CARDIOTONIC IMIDAZOLYLPHENYLPYRROL-2-ONE.